Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy
To access this article, please choose from the options below
PII: S1386-6532(06)00345-3
doi:10.1016/j.jcv.2006.09.009
© 2006 Elsevier B.V. All rights reserved.
